Vital Signs with Jacob Effron and Nikhil Krishnan

by Redpoint Ventures

On Vital Signs, Jacob Effron and Nikhil Krishnan dig into cutting-edge trends in healthtech and the people shaping them. Every two weeks they’ll explore a new sub-sector and trend with policy leaders, startup founders and industry executives. Subscribe now to make sure you don’t miss any of it!

  1. OCT 1

    Ep 63: Narayana Health Vice Chairman on Scaling Quality Care in India and Tech’s Role

    This episode features Viren Shetty, Vice Chairman of Narayana Health, discussing how his father founded a cardiac surgery hospital in India 25 years ago that revolutionized healthcare delivery by applying manufacturing efficiency principles to drastically reduce costs while maintaining quality. The conversation explores how Narayana Health scaled from one cardiac center to 19 multi-specialty hospitals across India and one in the Cayman Islands by implementing supply chain optimization, standardization of care, physician specialization, and high-volume operations—enabling them to perform cardiac surgeries at a fraction of Western costs. Shetty discusses the challenges and opportunities of operating in India's largely out-of-pocket healthcare market, the hospital's expansion into insurance and primary care to become a fully integrated provider, their measured approach to AI adoption, and why their high-volume, efficiency-driven model wouldn't directly translate to the US healthcare system despite offering valuable lessons in operational excellence and cost reduction.   (0:00) Intro (1:20) Founding and Growth of Narayana Health (2:48) Cost Reduction Strategies in Indian Healthcare (6:04) Challenges and Cultural Shifts in Standardization (8:16) Scaling and Expansion Bottlenecks (14:10) Impact of COVID-19 on Narayana Health (19:15) Medical Tourism and the Cayman Islands (23:03) High Patient Volume in Indian Hospitals (24:29) Exploring Healthcare Ecosystems (25:25) Automating Healthcare Administration (26:39) Challenges in US Healthcare (28:18) Innovative Healthcare Models (30:28) AI in Medicine (33:22) Driving Efficiency in Hospitals (37:48) Opportunities in Indian Healthcare (40:34) Quickfire   With your co-hosts:  @jacobeffron  - Partner at Redpoint, Former PM Flatiron Health  @patrickachase  - Partner at Redpoint, Former ML Engineer LinkedIn  @ericabrescia  - Former COO Github, Founder Bitnami (acq’d by VMWare)  @jordan_segall  - Partner at Redpoint

    46 min
  2. SEP 29

    Ep 62: Merck KGaA Chief Data and AI Officer on Scaling AI in Pharma and The Future of Enterprise Software

    This episode captures Walid Mehanna's perspective on how Merck KGaA has approached enterprise AI adoption through a federated strategy that prioritizes people over technology. The core message is that successful AI implementation requires building organizational capability across three dimensions - people, processes, and technology - rather than seeking a single transformative solution. Walid argues that companies must establish a broad foundation of AI literacy (exemplified by their internal MyGPT tool reaching 25,000 users) before pursuing specialized applications, while maintaining human accountability to prevent complacency. He emphasizes that AI works best when it's treated as an experimental, iterative capability distributed across the organization rather than controlled centrally, with success depending on persistence through the inevitable J-curve of initial productivity drops. The conversation reveals how a large multinational navigates the practical realities of AI deployment - from managing regulatory complexity across different geographies to making pragmatic build-versus-buy decisions - while maintaining focus on the fundamental principle that AI should augment human expertise rather than replace human judgment and responsibility.   (0:00) Intro (0:29) How AI is Used at Merck (2:18) AI Applications Across the Value Chain (4:31) Challenges and Risks of AI Implementation (5:35) Federated Approach to AI Prioritization (6:44) Future AI Use Cases and Data Challenges (10:38) Building and Partnering for AI Solutions (15:11) AI in Drug Discovery and R&D (26:47) Quickfire   Out-Of-Pocket: https://www.outofpocket.health/

    33 min
  3. SEP 22

    Ep 61: Co-Founder of Chai Discovery Joshua Meier on 99% Faster Drug Discovery, BioTech’s AlphaGo Moment, Building Photoshop for Molecules

    In this episode, Jacob sits down with Joshua Meier, co-founder of Chai Discovery and former Chief AI Officer at Absci, to explore the breakthrough moment happening in AI drug discovery. They discuss how the field has evolved through three distinct waves, with the current generation of companies finally achieving success rates that seemed impossible just years ago.    The conversation covers everything from moving drug discovery out of the lab and into computers, to why AI models think differently than human chemists, to the strategic decisions around open sourcing foundational models while keeping design capabilities proprietary. It's an in-depth look at how AI is fundamentally changing pharmaceutical innovation and what it means for the future of medicine.   Check out the full Chai-2 Zero-Shot Antibody report linked here: https://www.biorxiv.org/content/10.1101/2025.07.05.663018v1.full.pdf   (0:00) Intro (1:25) The Evolution of AI in Drug Discovery (5:14) Current State and Future of AI in Biotech (10:08) Challenges and Modalities in Therapeutics (14:44) Data Generation and Model Training (22:52) Open Source and Model Development at Chai (29:52) Open Source Models and Their Impact (34:36) How Should Chai-2 Be Used? (38:53) The Future of AI in Pharma and Biotech (42:46) Key Milestones and Metrics in AI-Driven Drug Discovery (47:20) Critiques and Hesitation (54:01) Quickfire   Out-Of-Pocket: https://www.outofpocket.health/

    57 min
5
out of 5
50 Ratings

About

On Vital Signs, Jacob Effron and Nikhil Krishnan dig into cutting-edge trends in healthtech and the people shaping them. Every two weeks they’ll explore a new sub-sector and trend with policy leaders, startup founders and industry executives. Subscribe now to make sure you don’t miss any of it!

You Might Also Like